Literature DB >> 28400896

Treatment of recalcitrant erosive oral lichen planus and desquamative gingivitis with oral apremilast.

Mohn'd AbuHilal1, Scott Walsh1, Neil Shear1.   

Abstract

BACKGROUND: Erosive oral lichen planus and desquamative gingivitis are uncommon but severe debilitating variants of oral lichen planus. Treatment of these presentations is difficult and challenging. MAIN OBSERVATION: A 44-year-old woman was referred to the dermatology clinic with chronic painful lichen planus-related gingivitis and buccal erosions. She has failed multiple treatments including topical clobetasol and tacrolimus, intralesional corticosteroids and several systemic and immunosuppressive agents. Following completion of three months of treatment with oral apremilast at a dose of 30 mg twice daily, significant improvement was noted in her disease activity.
CONCLUSION: Oral apremilast may be a safe and effective treatment for erosive oral lichen planus.

Entities:  

Keywords:  erosions; lichen planus; mucous membranes; oral cavity

Year:  2016        PMID: 28400896      PMCID: PMC5385266          DOI: 10.3315/jdcr.2016.1232

Source DB:  PubMed          Journal:  J Dermatol Case Rep        ISSN: 1898-7249


  11 in total

Review 1.  Pathogenesis of oral lichen planus--a review.

Authors:  M R Roopashree; Rajesh V Gondhalekar; M C Shashikanth; Jiji George; S H Thippeswamy; Abhilasha Shukla
Journal:  J Oral Pathol Med       Date:  2010-10-04       Impact factor: 4.253

2.  Use of Apremilast in Combination With Other Therapies for Treatment of Chronic Plaque Psoriasis: A Retrospective Study.

Authors:  Mohn'd AbuHilal; Scott Walsh; Neil Shear
Journal:  J Cutan Med Surg       Date:  2016-02-04       Impact factor: 2.092

3.  Apremilast for Behçet's syndrome--a phase 2, placebo-controlled study.

Authors:  Gulen Hatemi; Melike Melikoglu; Recep Tunc; Cengiz Korkmaz; Banu Turgut Ozturk; Cem Mat; Peter A Merkel; Kenneth T Calamia; Ziqi Liu; Lilia Pineda; Randall M Stevens; Hasan Yazici; Yusuf Yazici
Journal:  N Engl J Med       Date:  2015-04-16       Impact factor: 91.245

Review 4.  Oral lichen planus and lichenoid mucositis.

Authors:  Scott S De Rossi; Katharine Ciarrocca
Journal:  Dent Clin North Am       Date:  2014-04

Review 5.  Oral lichen planus.

Authors:  Justin Au; Dhaval Patel; John H Campbell
Journal:  Oral Maxillofac Surg Clin North Am       Date:  2013-02       Impact factor: 2.802

6.  Oral Lichen Planus Treated With Apremilast.

Authors:  Miriam Bettencourt
Journal:  J Drugs Dermatol       Date:  2016-08-01       Impact factor: 2.114

Review 7.  Apremilast: A Review in Psoriasis and Psoriatic Arthritis.

Authors:  Emma D Deeks
Journal:  Drugs       Date:  2015-08       Impact factor: 9.546

8.  An open-label pilot study of apremilast for the treatment of moderate to severe lichen planus: a case series.

Authors:  Joan Paul; Clare E Foss; Stefanie A Hirano; Tina D Cunningham; David M Pariser
Journal:  J Am Acad Dermatol       Date:  2012-08-19       Impact factor: 11.527

9.  Gingival involvement of oral lichen planus.

Authors:  Fabio Camacho-Alonso; Pía López-Jornet; Ambrosio Bermejo-Fenoll
Journal:  J Periodontol       Date:  2007-04       Impact factor: 6.993

10.  Oral lichen planus: An update on pathogenesis and treatment.

Authors:  N Lavanya; P Jayanthi; Umadevi K Rao; K Ranganathan
Journal:  J Oral Maxillofac Pathol       Date:  2011-05
View more
  4 in total

1.  Off-label studies on apremilast in dermatology: a review.

Authors:  Nolan J Maloney; Jeffrey Zhao; Kyle Tegtmeyer; Ernest Y Lee; Kyle Cheng
Journal:  J Dermatolog Treat       Date:  2019-04-02       Impact factor: 3.359

Review 2.  Therapeutic targeting of 3',5'-cyclic nucleotide phosphodiesterases: inhibition and beyond.

Authors:  George S Baillie; Gonzalo S Tejeda; Michy P Kelly
Journal:  Nat Rev Drug Discov       Date:  2019-08-06       Impact factor: 84.694

Review 3.  Therapeutic strategies for oral lichen planus: State of the art and new insights.

Authors:  Dario Didona; Raffaele Dante Caposiena Caro; Antonio Manuel Sequeira Santos; Farzan Solimani; Michael Hertl
Journal:  Front Med (Lausanne)       Date:  2022-10-04

4.  Apremilast for genital erosive lichen planus in women (the AP-GELP Study): study protocol for a randomised placebo-controlled clinical trial.

Authors:  Kristin Helene Skullerud; Petter Gjersvik; Are Hugo Pripp; Erik Qvigstad; Anne Lise Ording Helgesen
Journal:  Trials       Date:  2021-07-20       Impact factor: 2.279

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.